Southern Florida & Puerto Rico Chapter
www.lls.org/sfl
Local Staff Contacts
Southern Florida & Puerto Rico
200 S. Park Road Suite 140
Hollywood, FL 33021
(954) 744-5300 (phone)- Campaign Director - Special Events
- Bich-Ly Ludwig
- Bich-ly.Ludwig@lls.org
- 954-744-5234 (phone)
- Campaign Director - Light the Night
- Jill Nugent
- Jill.Nugent@lls.org
- 954-744-5311 (phone)
- Executive Director
- Emily Marquez
- Emily.Marquez@lls.org
- 954.744.5300 (phone)
- Patient Services Manager
- Seth Berkowitz
- Seth.Berkowitz@lls.org
- 954-744-5310 (phone)
- Community OutreachManager
- Vanessa Vicente
- Vanessa.Vicente@lls.org
- 954-744-5310 (phone)
- Special Events Senior Campaign Manager
- Rhonda Siegel
- rhonda.siegel@lls.org
- 954-744-5236 (phone)
- Team In Training Campaign Manager
- Karen Ciely
- karen.ciely@lls.org
- 954-744-5312 (phone)
- Special Events Campaign Manager
- Chantel Garcia
- chantel.garcia@lls.org
- 954 7445233 (phone)
- Team In Training Campaign Coordinator
- Monica Diaz
- monica.diaz@lls.org
- 954-744-5312 (phone)
- Light the Night Campaign Coordinator
- Hebe Occupati
- Hebe.Occupati@lls.org
- 954-744-5311 (phone)
- Office Manager
- Maria Herrera
- maria.herrera@lls.org
- 954-744-5226 (phone)
- Volunteer Coordinator
- Marty Rubin
- marty.rubin@lls.org
- 954-744-5243 (phone)
- Campaign Coordinator
- Ligia Santos Rivera
- Ligia.SantosRivera@lls.org
- 787-725-2200 (phone)
About the Southern Florida Chapter
The Leukemia & Lymphoma Society's Southern Florida Chapter was founded in 1972 to serve residents who have been touched by one of the blood cancers: leukemia, lymphoma and myeloma. The chapter serves Miami-Dade, Broward, Monroe, Lee and Collier counties in Florida. The chapter also serves Puerto Rico and the US Virgin Islands.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS), based in White Plains, NY, is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since it was founded in 1949, LLS has invested more than $750 million in research specifically targeting blood cancers.
